Quantcast

Latest Nerve Stories

2014-09-16 23:10:39

Company to exhibit nerve repair technologies at Booth 205 Alachua, FL (PRWEB) September 16, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, announced that it will sponsor an educational forum at the American Society for Surgery of the Hand (ASSH) 2014 Annual Meeting, taking place September 18-20 at the John B. Hynes Convention Center in Boston, MA. The event, entitled “Nerve Matters”, will focus on improving...

2014-09-09 23:09:16

Company to exhibit nerve repair technologies at Booth 644 Alachua, FL (PRWEB) September 09, 2014 A xoGen, Inc. (NASDAQ: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, today announced that it will sponsor a panel discussion at the 96th Annual Meeting of the American Association of Oral and Maxillofacial Surgeons (AAOMS), taking place this week in Honolulu, HI. The Company will also demonstrate its full portfolio of nerve repair...

2014-08-25 23:01:57

PDL BioPharma President & CEO John McLaughlin to step down. Alachua, FL (PRWEB) August 25, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, reported today that John McLaughlin, President and Chief Executive Officer of PDL BioPharma, Inc. has resigned from AxoGen’s Board of Directors. Mr. McLaughlin joined AxoGen’s Board in 2012 as part of the Revenue Interest Purchase Agreement between AxoGen and PDL. At this...

2014-08-07 15:39:20

Salk Institute Scientists hope to borrow strategy from simpler animals to repair damaged spinal cord nerves in humans Frogs, dogs, whales, snails can all do it, but humans and primates can't. Regrow nerves after an injury, that is—while many animals have this ability, humans don't. But new research from the Salk Institute suggests that a small molecule may be able to convince damaged nerves to grow and effectively rewire circuits. Such a feat could eventually lead to therapies for the...

2014-08-05 23:07:42

Nerve repair company AXGN to participate in investor conference in New York Alachua, FL (PRWEB) August 05, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, is scheduled to present at the Wedbush 2014 Life Sciences Management Access Conference on Tuesday, August 12, 2014 at 10:55am (ET) at Le Parker Meridien Hotel in New York City. A live webcast and subsequent archived replay of the Company’s...

2014-07-15 23:05:17

Nerve repair company to announce results and host call for investors. Alachua, FL (PRWEB) July 15, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, will report results for the second quarter ended June 30, 2014 on Monday, August 4, 2014 after the close of the markets. The Company will host a conference call and webcast for the investment community on Monday, August 4, 2014 at 4:30 PM ET. Investors within the United...

2014-06-18 23:11:38

Expanded outcomes data from the Ranger® Registry to be presented Alachua, FL (PRWEB) June 18, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, today announced the acceptance of two clinical presentations on the use of Avance® Nerve Graft and a scientific presentation on the use of coaptation aids in nerve repair at the 29th Congress of the Federation of European Societies for Surgery of the Hand (FESSH), June...

2014-06-09 23:07:46

Nerve Repair Company AXGN to participate in investor conference in New York Alachua, FL (PRWEB) June 09, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, is scheduled to present at the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24, 2014 at 12:30pm (ET) at the Westin New York Grand Central. A live webcast and subsequent archived replay of the Company’s presentation may be accessed...

2014-06-04 23:10:04

$1.9 Million in Grant funding will explore application of novel stem cells and development of branched grafts for complex nerve repair Alachua, FL (PRWEB) June 04, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, announced today that it would share in the award of two Department of Defense Grants totaling approximately $1.9 million with Brigham and Women’s Hospital in Boston (BWH). The grants, awarded to Principal...

2014-05-13 15:21:34

Elsevier Health Sciences Corneal nerve fiber assessment proposed for managing patients with HIV-induced peripheral neuropathy, according to The American Journal of Pathology Corneal nerve fiber assessment has great potential as a tool to diagnose and monitor peripheral neuropathy induced by HIV, say scientists at the Johns Hopkins University School of Medicine. The results of their study are published in The American Journal of Pathology. Although corneal nerve assessments have shown...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related